Question 1

What are the potential benefits of using CP-690,550 compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients clinical trial (NCT00483756). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with this new medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients clinical trial (NCT00483756). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for check-ups during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients clinical trial (NCT00483756). Contact the study team or your healthcare provider for specific answers.

Question 4

What other medications will I need to take alongside CP-690,550?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients clinical trial (NCT00483756). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients clinical trial (NCT00483756). Contact the study team or your healthcare provider for specific answers.

What this study is about